U.S., Sept. 17 -- An application to own the trademark for 'NEXTPOINT' has been filed on Mar. 10, 2025.
Owner(s):
NextPoint Therapeutics, Inc.; 238 Main Street, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceutical products for the treatment of cancer; Antibodies for medical purposes
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Class(es): 001, 005, 006, 010, 026, 046
For: Pharmaceutical products development; Pharmaceutical research and development; Research and development of medicines; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Medi...